Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

xDRIVE Functional Precision Medicine + Artificial Intelligence Individualized Treatments for Florida-based Cancer Patients With Relapsed/ Refractory Cancers

NCT07167381 is registered in ClinicalTrials.gov with First Ascent Biomedical Inc. as lead sponsor.

NCT NCT07167381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07167381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
xDRIVE Functional Precision Medicine + Artificial Intelligence Individualized Treatments for Florida-based Cancer Patients With Relapsed/ Refractory Cancers
Lead sponsor
First Ascent Biomedical Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2025
Completion date
April 1, 2027
Enrollment
210 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, leukaemia, lymphoma, neoplams, recurrence, refractory, solid cancers, solid tumor malignancies